Scientific Advisory Board

In order to maintain the highest standard of research, the IMP has installed a process of review and feedback: the Scientific Advisory Board (SAB), consisting of internationally recognized scientists. The Board meets yearly at the IMP, and, together with IMP researchers, discusses the quality, significance, and main focus of research conducted at the IMP.

 

Prof. Angelika Amon
MIT
Cambridge, USA


Prof. Anton Berns
Netherlands Cancer Institute
Amsterdam, The Netherlands

 

Prof. Tobias Bonhoeffer
MPI Martinsried
Germany

 

Prof. Dr. Norbert Kraut
Boehringer Ingelheim RCV GmbH
Vienna, Austria 

Dr. Venki Ramakrishnan
MRC
Cambridge, UK

Prof. Dr. Wolfgang Rettig
Boehringer Ingelheim GmbH
Ingelheim, Germany

Prof. Cornelia Bargmann
Rockefeller University
New York, USA (Chair)

 

Dr. Ewan Birney
EMBL-EBI
Hinxton, UK

 

Prof. Rudolf Jaenisch
The Whitehead Institute
Cambridge, USA


Dr. Dan Littman
NYU Langone Medical Center
New York, USA

 

Prof. Tom Rapoport
Harvard Medical School
Boston, USA